Upon exploring the correlation between DED and psychiatric factors among Koreans aged ≥ 20 years, this study showed that the risk of DED increased with short sleep duration, stress perception, and depressive symptoms. This result was in keeping with the results of previous studies. This study also showed that the risk of DED was the highest in those with severe mental health issues (those experiencing all three aforementioned factors).
DED is a common irritating eye disease that causes pain, discomfort, burning, a foreign body sensation, and blurred vision. Previous studies have evaluated the association between psychological problems and eye disease, such as age-related macular degeneration (AMD), cataract, glaucoma, and DED21. DED has a known association with mental health problems, such as depression and anxiety22. A meta-analysis evaluating the correlation between eye disease and depression showed that the prevalence of depression was 29% among patients with DED, 25% in patients with glaucoma, 24% in patients with AMD, and 23% in patients with cataract, showing the highest prevalence among patients with DED21.
Wan et al.22 stated that the depression and anxiety score in patients with dry eye symptoms were higher than that in the control group, which was similar to the results obtained from this study. Ayaki et al.23 evaluated the correlation between sleep, anxiety, and depression in 301 patients with DED and 202 patients with other ocular surface diseases (chronic conjunctivitis/ allergic conjunctivitis). They showed that the mild to severe DED group showed a higher proportion of patients presenting with problems with sleep quality based on a Pittsburgh Sleep Quality Index of ≥ 6, as well as depression symptomology based on a Hospital Anxiety and Depression Scale Depression Subscale score of ≥ 5, when compared with the chronic conjunctivitis or allergic conjunctivitis groups.
Lee et al.16 evaluated the association between sleep duration and dry eye syndrome (DES) in Korean adults. They showed that the prevalence of DES was 1.20 and 1.29-fold higher in the short sleep duration group (5 h/day) and in the severe sleep disruption group (≤ 4 h/day), respectively, compared with the optimal sleep group (6 ~ 8 h/day), showing that the prevalence of DES increased with shorter sleep duration. This is thought to be due to the stress from sensory discomfort or optical disturbance experienced by patients with DED as well as sleep difficulty from inflammatory processes (pain, brightness due to in-complete eye closure, and others) during sleep. Previous studies also show that persistent positive airway pressure, a treatment option for obstructive sleep apnea, may exacerbate DED24.
Depression is more closely associated with dry eye symptoms compared with dry eye signs25,26. Irritating ocular surface symptoms exert negative effect on visual performance and daily activity27. Momoko et al.28 evaluated the association between psychiatric symptoms and objective measures (BUT, Schirmer value, Fluorescein staining score) in 56 patients with DED. To quantify psychiatric symptoms, the Montgomery-Asberg Depression Scale (MADRS) and HAM-A (Japanese version of the Hamilton Rating Scale for Anxiety) scales were used. Subjects were divided into those with normal MADRS and HAM-A scores and those with high MADRS and HAM-A scores to compare the differences in subjective symptoms of DED with objective measures. There was a significant difference in subjective symptoms of DED, whereas no significant difference was observed in the objective measures (BUT, Schirmer value, fluorescein staining score).
Galor et al.29 stated that patients with depression and anxiety can have central sensitization, which may affect pain perception. In other words, patients with depression or anxiety may react more sensitively to ocular sensation compared to control participants22 and experience persistent irritation from eye dryness, and this in turn can cause or exacerbate mood disorders30.
Furthermore, inflammatory cytokines play an important role in the pathogenesis of depression by triggering unhealthy behavior. Lymphocytes of a patient with depression activate the production of IL-1b, IL-6 and TNF- α and such inflammatory pathways are known to cause neuronal damage through oxidative and nitrosative stress31,32. Mrugacz et al.33 explored the correlation between inflammatory cytokine levels in tears and depression among 32 (14 male, 18 female) DED patients with an average age of 44.21 years, observing that patients with depression have significantly higher inflammatory cytokines (IL-6, IL-17, and TNF- α) levels in tears than control participants, which reflects the severity of local immunological changes. In particular, locally increased IL-17 and TNF-a levels in tear fluid can be considered a result of DED progression, which implies that IL-17 and TNF-a levels can be used as predictive factors for clinical inflammation in dry eye patients with depression33.
In some patients with DED, tear production may have been compromised from using somnifacients containing anticholinergic agents34. Human conjunctival epithelium contains muscarinic and adrenergic receptors, which implies that antidepressants could plausibly affect the ocular surface38. Chronic exposure to histamines and 5-hydroxytryptamine changes function through secretory processes, and neuronal release of 5-hydroxytryptamine could plausibly affect acute control of lacrimal secretion. Zheng et al.21 stated that chronic painful symptoms from dry eye disease can induce depression and that medications used to treat depression can cause or exacerbate dry eye disease. Ayaki et al.23 stated that steroid or mucin secretagogue eye drops (diquafosol and re-bamipide) used to relieve severe DED symptoms can cause distress. Sleep deprivation and medication history due to psychiatric disorders may partially inhibit tear secretion, since lacrimal secretion is under neural regulation.
Thus far, not much is known regarding the pathogenesis of DED, and it is yet unclear whether depression exacerbates DED. Ayaki et al.18 hypothesized that DED causes distress, which can in turn give rise to depression and sleep disorders. Furthermore, eye pain and exposure to light from DED can cause sleep disturbance, which would in turn lead to sleep disorders. The inverse may also be possible, such that the presence of sleep disorder can cause DED and depression.
Irritating ocular symptoms can exert negative influence on visual performance23 through tear instability from DED that leads to blurred vision, which may hinder daily activities. Furthermore, DED patients can experience stress from sensory discomfort or optical disturbance, and the condition itself can cause psychological distress. DED patients experience pain and brightness due to incomplete eye closure, which can cause sleep disturbance. Such disturbance can produce inflammatory processes. Patients with Sjogren’s syndrome are known to experience various sleep disorders such as pain, night awakenings, long sleep latency, and obstructive sleep apnea18.
A major strength of this study is the fact that it is the first large-scale population-based study that corrects for history of ocular surgery, including refractive and cataract surgery, and evaluates the association between DED and mental health and sleep disorders. Previous studies among Asians9,16 did not consider history of ocular surgery, although DED is the most common complication of LASIK and cataract surgery. This study was conducted among 16,471 South Korean adults aged ≥ 20 years. Korea is a single-race country with relatively uniform genetic and environmental influences. Therefore, the results of this study are more consistent than other large population-based studies and should be broadly generalizable.
However, the following limitations must be considered. First, a cross-sectional study can identify correlation between DED and psychiatric factors, although it cannot establish a causal relationship. Second, this survey was not designed to diagnose DED, examinations related to the severity of DED were not performed. Nevertheless, many previous studies have used this data to investigate DED and its risk factors9,12,16. Third, the evaluation of sleep duration was performed through surveys. Therefore, future studies would require objective evaluation of sleep quality (actigraphy, melatonin measurement, and polysomnography) in patients with DED.
In conclusion, this study provides epidemiologic evidence that DED is associated with sleep duration, stress, and depression in the Korean population. Short sleep duration (≤ 5 h/night), stress perception, and depressive symptoms were significantly associated with the risk of DED even after correcting for demographic factors, lifestyle factors, and medical factors. When all three factors were present, in other words, in the case of severe mental health issues, the risk of DED increased greatly. Therefore, ophthalmologists must be aware of the possibility of stress and depression among patients with DED.